109 Results for "

CK2,

" in MedChemExpress (MCE) Product Catalog:
Products (109)

109 Results for "CK2," in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-14393R
CAS No.: 518-82-1
Synonyms: Frangula emodin (Standard)
Emodin (Standard) is the analytical standard of Emodin. This product is intended for research and analytical applications. Emodin (Frangula emodin), an anthraquinone derivative, is an anti-SARS-CoV compound. Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 (ACE2) interaction . Emodin inhibits casein kinase-2 (CK2). Anti-inflammatory and anticancer effects [2]. Emodin is a potent selective 11β-HSD1 inhibitor with the IC50 of 186 and 86 nM for human and mouse 11β-HSD1, respectively. Emodin ameliorates metabolic disorder in diet-induced obese mice .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P76263
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: CSNK2A1; Casein Kinase II Alpha 1 Polypeptide Pseudogene; Casein Kinase 2 Alpha 1; Non-Specific Serine/Threonine Protein Kinase; Casein Kinase II Subunit Alpha; Casein Kinase II Alpha 1 Subunit; CKa1; CK2 Catalytic Subunit Alpha; CKa2; Protein Kinase CK2
Species:  
Human
Source:  
Sf9 insect cells
loading...
    loading...
Cat. No.: HY-132175
CAS No.: 2641079-92-5
Purity:  98.51%
Target:  

Casein Kinase

Research Areas:  

Cancer

CK2 inhibitor 2 is a potent, selective and orally active inhibitor of CK2, with an IC50 of 0.66 nM. CK2 inhibitor 2 shows high selectivity for Clk2 (IC50=32.69 nM)/CK2. CK2 inhibitor 2 exhibits favorable antiproliferative and antitumor activity .
loading...
    loading...
Cat. No.: HY-124833
CAS No.: 81-61-8
Purity:  97.1%
Quinalizarin is a protein kinase CK2 inhibitor with a Ki of 0.052 μM. Quinalizarin exhibits antifungal and anticancer activities. Quinalizarin induces ROS production, apoptotic signaling, mitochondrial pathway activation, cell cycle arrest, and cytotoxicity in cancer cells. Quinalizarin inhibits hyphal growth, biofilm formation, and mature biofilm integrity of Candida albicans. Quinalizarin can be used in research related to cancer and fungal infections [2] .
loading...
    loading...
Cat. No.: HY-156816
CAS No.: 1585246-23-6
Purity:  99.73%
Synonyms: 108600
Research Areas:  

Cancer

ON 108600 (108600) is a CK2 (CK2α1: IC50 = 50 nM; CK2α2 = 5 nM), TNIK (IC50 = 5 nM) and DYRK (DYRK1A: IC50 = 16 nM; DYRK1B = 7 nM; DYRK2: = 28 nM). ON 108600 suppresses the growth of CD44high/CD24low breast cancer stem cell (BCSC) populations, induces G2/M arrest and apoptosis in triple negative breast cancer (TNBC) cells, and inhibits tubulin polymerization. ON 108600 can be used for the study of chemotherapy-resistant and metastatic TNBC [2].
loading...
    loading...
Cat. No.: HY-145260
CAS No.: 2756851-99-5
Purity:  98.21%
BRD4/CK2-IN-1 is the first highly effective and oral active dual-target inhibitor of BRD4/CK2 (bromodomain-containing protein 4/casein kinase 2), with IC50s of 180 nM and 230 nM for BRD4 and CK2, respectively. BRD4/CK2-IN-1 has strong anticancer activity without obvious toxicities. BRD4/CK2-IN-1 induces apoptosis and autophagy-associated cell death in triple-negative breast cancer (TNBC)
loading...
    loading...
Cat. No.: HY-149006
CAS No.: 2910938-59-7
Purity:  99.91%
Target:  

DAPK

Research Areas:  

Inflammation/Immunology Cancer

CK156, a chemical probe, is a highly selective death-associated protein kinase (DAPK) inhibitor with IC50s of 182 nM,34 μM, and 39 μM in the DRAK1 NanoBRET assay for DRAK1, CK2a1, and CK2a2, respectively. CK156 can be used for the research of autoimmune and inflammatory diseases .
loading...
    loading...
Cat. No.: HY-P4056A
Synonyms: P15-Tat acetate
Target:  

Casein Kinase Apoptosis

Research Areas:  

Cancer

CIGB-300 acetate (P15-Tat acetate) is an anti-casein kinase 2 (CK2) peptide that exhibits anticancer properties by interfering with the phosphorylation of protein kinase CK2. CIGB-300 acetate induces apoptosis in multiple tumor cell lines and can be used in cancer research .
loading...
    loading...
Cat. No.: HY-50733A
CAS No.: 1333382-30-1
Research Areas:  

Cancer

CX-5011 is a CK2 inhibitor. CX-5011 also induces Rac1 activation. CX-5011 induces apoptosis and induces cancer cell death [2].
loading...
    loading...
Cat. No.: HY-124321
CAS No.: 53734-79-5
Target:  

CDK

Research Areas:  

Cancer

Metralindole hydrochloride is an inhibitor of human cyclin-dependent kinase CDK2 and human protein kinase CK2 holoenzyme. Metralindole hydrochloride shows good potential as a non-small cell lung cancer inhibitor .
loading...
    loading...
Cat. No.: HY-114653
CAS No.: 380572-02-1
Purity:  99.17%
Target:  

Casein Kinase SRPK

Research Areas:  

Cancer

SRPIN803 is a potent CK2 and SRPK1 dual inhibitor, with IC50s of 203 nM and 2.4 μM, respectively. SRPIN803 exhibits antiangiogenic activity. SRPIN803 can be used for the research of age-related macular degeneration [2] .
loading...
    loading...
Cat. No.: HY-148318
CAS No.: 443747-52-2
Purity:  98.34%
Target:  

Casein Kinase

Research Areas:  

Cancer

CK2α-IN-1 (compound 2) is a selective CK2α inhibitor (IC50=7.0 µM; Ki=1.6 µM) that exhibits a non-ATP-competitive mode of action. CK2α-IN-1 exhibits good potential for anticancer studies .
loading...
    loading...
Cat. No.: HY-P4056
CAS No.: 1072877-99-6
Synonyms: P15-Tat
Target:  

Casein Kinase Apoptosis

Research Areas:  

Cancer

CIGB-300 (P15-Tat) is an anti-casein kinase 2 (CK2) peptide that exhibits anticancer properties by interfering with the phosphorylation of protein kinase CK2. CIGB-300 induces apoptosis in multiple tumor cell lines and can be used in cancer research .
loading...
    loading...
Cat. No.: HY-E70625
Target:  

Casein Kinase

Research Areas:  

Cancer

Casein Kinase 2 (CK2) is a serine/threonine protein kinase that is highly conserved among eukaryotes and has roles in many different cellular processes, such as cell survival, cell cycle regulation, cell polarity, stress responses, transcription and translation .
loading...
    loading...
Cat. No.: HY-158369
CAS No.: 831207-32-0
Target:  

Casein Kinase

Research Areas:  

Cancer

CK2-IN-10 (31), an allosteric CK2 inhibitor, can be used in the research of cancer .
loading...
    loading...
Cat. No.: HY-148328
CAS No.: 313985-59-0
Purity:  99.24%
Target:  

Casein Kinase

CK2-IN-4 (compound 5) is a protein kinase (CK2) inhibitor (IC50=8.6 µM). CK2-IN-4 has good potential for research in the areas of cancer, viral infections and glomerulonephritis .
loading...
    loading...
Cat. No.: HY-15424R
CAS No.: 24386-93-4
Synonyms: NSC 113939 (Standard); 5-ITu (Standard)
Research Areas:  

Cancer

5-Iodotubercidin (Standard) is the analytical standard of 5-Iodotubercidin. This product is intended for research and analytical applications. 5-Iodotubercidin (NSC 113939), an ATP mimetic, is a potent adenosine kinase inhibitor with an IC50 of 26 nM. 5-Iodotubercidin (NSC 113939) initiates glycogen synthesis in isolated hepatocytes by causing inactivation of phosphorylase and activation of glycogen synthase. 5-Iodotubercidin (NSC 113939) also inhibits CK1, insulin receptor tyrosine kinase, phosphorylase kinase, PKA, CK2, PKC and Haspin [2] .
loading...
    loading...
Cat. No.: HY-P3921
CAS No.: 95651-74-4
Target:  

Casein Kinase

Research Areas:  

Cancer

Casein Kinase II Substrate is a casein kinase II (CK2) peptide substrate that can be selectively phosphorylated by CK2 .
loading...
    loading...
Cat. No.: HY-103384
CAS No.: 905105-89-7
Target:  

Casein Kinase

Research Areas:  

Cancer

TMCB is a selective, ATP-competitive CK2 (casein kinase II) inhibitor with distinct Ki values of 83 nM and 21 nM for the two different catalytic CK2 subunits α and α', respectively .
loading...
    loading...
Cat. No.: HY-176561
CAS No.: 2421119-78-8
Target:  

Casein Kinase HDAC

Research Areas:  

Cancer

IOR-160 is a dual inhibitor of casein kinase 2 (CK2) and HDACs. IOR-160 exhibits high selectivity for CK2 (IC50 = 1.7 nM) and broad inhibitory activity against HDAC (HDAC 1, 2, 3, and 6 with IC50s of 3.3 nM, 24.0 nM, 3.9 nM, and 13.0 nM, respectively, with low activity for HDAC8). IOR-160 modulates key cellular signaling pathways by inhibiting AKT phosphorylation and increasing acetylated α-tubulin. IOR-160 inhibits tumor growth and reduces tumor burden through dual CK2/HDAC inhibition. IOR-160 is indicated for use in triple-negative breast cancer research .
loading...
    loading...